Patents
Patents for A61P 41 - Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution (3,707)
05/2012
05/10/2012US20120115846 Quinazolinedione derivatives, preparation thereof and various therapeutic uses thereof.
05/10/2012US20120115810 Surgical compositions for reducing the incidence of adhesions
05/10/2012US20120115803 Treatment of acinetobacter with alginate oligomers and antibiotics
05/10/2012US20120114755 Methods and materials for tissue repair
05/10/2012US20120114729 Silicone-peroxide compositions for long-term, controlled oxygen release
05/10/2012US20120114589 Swellable biodegradable polymeric matrices and methods
05/09/2012CN102448442A Treatment of tissue adhesion
05/09/2012CN102443061A High-functional antibody biological synthesis
05/09/2012CN102441179A Silicon dioxide base ultrasonic contrast medium/high intensity focused ultrasound (HIFU) synergist and preparation method thereof
05/08/2012CA2478655C Ester derivatives of hyaluronic acid for the preparation of hydrogel materials by photocuring
05/08/2012CA2340593C Use of vegf-c or vegf-d gene or protein to prevent restenosis
05/03/2012US20120107362 Neurotoxins exhibiting shortened biological activity
05/02/2012CN102430034A Medicine composition for enhancing wound healing after cesarean section and applications
05/02/2012CN102048715B Applications of trans-acomhole in preparing medicine or health care products
05/02/2012CN102008524B Application of volatile oil of foeniculum vulgare Mill. to preparation of medicament for preventing postoperative abdominal adhesion
04/2012
04/26/2012US20120101136 5-membered heteroaryl derivatives used as sphingosine 1- phosphate receptor agonists
04/26/2012US20120101123 Compounds
04/26/2012US20120101086 Thiadiazole derivatives and their use for the treatment of disorders mediated by s1p1 receptors
04/26/2012US20120101028 Anti-inflammatory compounds and uses thereof
04/26/2012US20120100079 Stimuli-responsive carriers for mpi-guided drug delivery
04/19/2012US20120094994 Functionalized amino acids and absorbable polymers therefrom
04/19/2012US20120094945 Discovery of Selective Glucocorticoid Receptor Modulators by Multiplexed Reporter Screening
04/19/2012US20120093877 Collagen scaffold for cell growth and a method for producing same
04/18/2012EP1830856B1 Preventing pathological increases in the rate of nerve cell suicide in immature nervous systems
04/17/2012CA2427844C Naphthalene derivatives
04/12/2012WO2012048289A1 Anti-adhesive barrier membrane using alginate and hyaluronic acid for biomedical applications
04/12/2012US20120088783 Chroman derivatives
04/11/2012EP2437596A1 Skin treatment compositions
04/11/2012CN202184953U 载抗肿瘤药物术后防粘连膜 Upload anticancer drugs after anti-adhesion film
04/05/2012US20120083492 Imidazopyrazines for use as kinase inhibitors
04/04/2012EP2435026A1 Treatment of tissue adhesion
04/04/2012CN102405049A 多糖类衍生物的水凝胶 Polysaccharide derivative hydrogels
04/04/2012CN102399295A Low-sulfhydrylation-modification-degree biocompatible high-molecular sulfhydrylation derivatives, cross-linking material thereof, and purpose thereof
03/2012
03/29/2012US20120077798 Azetidine and cyclobutane derivatives as jak inhibitors
03/22/2012US20120071460 Pyrazole oxadiazole derivatives as s1p1 agonists
03/15/2012US20120064165 Treatment of tissue adhesion
03/15/2012US20120064060 Compound having s1p receptor binding potency and use thereof
03/15/2012CA2810590A1 Mercapto-modified biocompatible macromolecule derivatives with low degree of mercapto-modification and the cross-linked materials and uses thereof
03/08/2012WO2012030030A1 Chitosan derivative of a type cured by visible light and a use for the same as a medical raw material
03/08/2012WO2012002986A3 Decellularized and delipidized extracellular matrix and methods of use
03/08/2012US20120059462 Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor
03/07/2012EP2425841A1 Methods Employing and Compositions Containing Defined Oxidized Phospholipids for Prevention and Treatment of Atherosclerosis
03/06/2012US8128924 Methods for using a three-dimensional stromal tissue to promote angiogenesis
03/06/2012CA2611441C Solution for tissue adhesion prevention and method for tissue adhesion prevention
03/06/2012CA2454592C Stable ready-to-use dosage forms containing coloring matter and active chlorine, and methods of making and using same as disinfectants
03/01/2012US20120053186 2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors
02/2012
02/29/2012EP2421373A1 Colon lavage system
02/29/2012CN101657205B Agent for preventing bleeding from cerebral cortical vein
02/28/2012US8124586 Prevention and reduction of blood loss
02/23/2012WO2012024072A1 Compositions comprising adipose tissue and a pge2 analogue and their use in the treatment of a soft tissue condition
02/23/2012US20120045418 Pharmaceutical preparation comprising supernatant of blood mononuclear cell culture
02/22/2012EP2420517A1 Polysaccharide derivative and hydrogel thereof
02/16/2012WO2012021818A2 Ggf2 and methods of use
02/16/2012WO2011151731A3 Surgical adjuvant composition and associated methods of use
02/16/2012US20120040997 Vinyl-aryl derivatives for inflammation and immune-related uses
02/16/2012US20120040928 Methods and compositions for inhibiting cellular proliferation and surgical adhesion
02/15/2012CN102355903A A dose of ave5026 for the treatment of venous thromboembolism in patients with severe renal impairment
02/09/2012WO2012018790A2 Dual variable domain immunoglobulins and uses thereof
02/09/2012WO2012017449A1 Process for preparation of novel 42-0-(heteroalkoxyalkyl) rapamycin compounds with anti-proliferative properties"
02/09/2012US20120035128 Polysaccharide derivative and hydrogel thereof
02/09/2012US20120034160 Dual variable domain immunoglobulins and uses thereof
02/02/2012US20120027814 Polymeric Fibers Having Tissue Reactive Members
02/01/2012EP2411021A2 Method for suppressing or preventing fibrous adhesion formation using a multicomponent aqueous oxychlorine composition prepared on-site
01/2012
01/26/2012US20120022034 Methods for reducing or neovascularization or edema
01/26/2012US20120021014 Corrosion current-generating metal particulates and use thereof
01/26/2012US20120020962 Method of depleting regulatory t cell
01/25/2012EP2408459A1 A dose of ave5026 for the treatment of venous thromboembolism in patients with severe renal impairment
01/18/2012EP2405748A1 Administration of intravenous ibuprofen
01/18/2012CN102319180A Preparation methods of ligustrazine nanoparticle solution and spraying agent thereof
01/17/2012CA2429998C Intraocular implants for preventing transplant rejection in the eye
01/05/2012WO2012002986A2 Decellularized and delipidized extracellular matrix and methods of use
01/05/2012US20120004160 Methods for identifying and compounds useful for the diagnosis and treatment of diseases involving inflammation
01/04/2012EP2400963A1 Compositions for use in cardioplegia comprising esmolol and adenosine
01/04/2012EP1339663B1 Naphthalene derivatives
01/03/2012US8088407 Method for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor
12/2011
12/29/2011WO2011162633A1 Soft cationic mitochondrial uncouplers
12/28/2011EP2399589A1 Hydrogel of polysaccharide derivatives
12/28/2011CN102300566A 血管收缩剂的皮肤应用 Skin application vasoconstrictor
12/22/2011US20110312936 Cyclohexyl-azetidinyl antagonists of ccr2
12/20/2011US8080641 Process for the production of multiple cross-linked hyaluronic acid derivatives
12/15/2011US20110306555 Biologic replacement for fibrin clot
12/15/2011US20110305719 Inhibition of Pro-Inflammatory Cytokine Induced Response
12/14/2011CN101693039B 一种用于手术冲洗的药物组合物 A pharmaceutical composition surgical flushing
12/13/2011CA2392666C Dextrin containing compositions for prevention of adhesions
12/08/2011WO2011151731A2 Surgical adjuvant composition and associated methods of use
12/08/2011US20110301157 Bicyclic amides as kinase inhibitors
12/08/2011US20110301121 Hydrogel of polysaccharide derivative
12/08/2011DE102010022567A1 Zubereitung Preparation
12/06/2011US8071120 biodegradable drug delivery system containing an immunosuppressive agent and a bioerodible polymer comprising hydroxyaliphatic carboxylic acids, and polysaccharides
12/01/2011US20110293749 Surgical Adjuvant Composition and Associated Methods of Use
11/2011
11/30/2011CN102258792A 质粒pUDK-SPK1在预防或治疗组织粘连中的应用 Plasmid pUDK-SPK1 application in the prevention or treatment of tissue adhesion
11/24/2011US20110288101 Surgical compositions containing sigma-receptor agonists
11/24/2011US20110287088 Modulation of olfml-3 mediated angiogenesis
11/23/2011EP1581254B1 Pharmacological vitreolysis using truncated plasmin
11/17/2011US20110280830 Albumin Fusion Proteins
11/09/2011CN101716185B Anti-adhesion agent and preparation process thereof
11/08/2011CA2525405C Compositions for repairing and regenerating human dura mater
11/03/2011US20110268724 Methods and materials relating to cd84-like polypeptides and polynucleotides
11/02/2011EP2383272A1 Active blood coagulation factor inhibitor
11/02/2011CN102231985A Composition for preventing adhesion
1 2 3 4 5 6 7 8 9 10 11 12 13 14 ... 38